Last line therapy with sorafenib in colorectal cancer: A retrospective analysis.
Martchenko K, Schmidtmann I, Thomaidis T, Thole V, Galle PR, Becker M, Möhler M, Wehler TC, Schimanski CC.
Martchenko K, et al.
World J Gastroenterol. 2016 Jun 21;22(23):5400-5. doi: 10.3748/wjg.v22.i23.5400.
World J Gastroenterol. 2016.
PMID: 27340356
Free PMC article.
Charts of identified patients were analyzed for clinic-pathological parameters, like data on gender, age, date of initial diagnosis, UICC stage, number and kind of the pre-therapies, therapy start and end of sorafenib, sorafenib mediated treatment cessation, side ef …
Charts of identified patients were analyzed for clinic-pathological parameters, like data on gender, age, date of initial diagnosis, …